Whatever finding on cPRA, delisting algorithm, prognostic indicator, or ABMR diagnosis which was based in MFI cutpoints, must now be reevaluated and amended based on the correction factor generated in this study to make MFI from the two Luminex platforms comparable:
pubmed.ncbi.nlm.nih.gov/41241990/
pubmed.ncbi.nlm.nih.gov/41241990/
pubmed.ncbi.nlm.nih.gov A comprehensive comparative assessment of mean fluorescence intensity of luminex single antigen... Reliable and reproducible testing of Donor Specific HLA-Antibodies (DSA) is essential for clinical decisions in organ transplantation. In this prospective multicentre study from the Italian Transpl... 